The Future of Psychedelic Medicine
Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
People globally are affected by a form of depression.
Dollars lost annually in global workforce productivity due to depression and anxiety.
Formulas standardized across clinical studies of psychedelic compounds.
HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
The Company Signs Supply Agreement with Nectar Health Sciences Laboratory Division Inc. to provide naturally derived psilocybin for research and development of therapeutic products Vancouver, …
HAVN Life Enters into Agreement to Distribute its Line of Natural Health Products with Australia’s Woke Pharmaceuticals
The Agreement gives Woke Pharmaceuticals exclusive White Label and Distribution rights to HAVN Life products in Australia, New Zealand and China through retail and e-commerce …
Vancouver, BC – HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces the departure of Mr. Rick …